Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
NCT00244465 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 750
Last updated 2016-09-07
Summary
Patients will be followed up for max 18 months. Information on the Adverse Events and potential misuse or abuse of Xyrem ® will be collected.
Conditions
Sponsors & Collaborators
-
UCB Pharma
lead INDUSTRY
Principal Investigators
-
UCB Cares · +1 877 822 9493 (UCB)
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-05-31
- Primary Completion
- 2016-09-30
- Completion
- 2016-09-30
Countries
- Austria
- Belgium
- Czechia
- Germany
- Ireland
- Italy
- Spain
- Switzerland
- United Kingdom
Study Locations
More Related Trials
-
Cardiovascular Safety After Continuous Ketamine Infusion
NCT03979105 ·Status: COMPLETED
-
Endogenous Opioid Modulation by Ketamine
NCT03051945 ·Status: WITHDRAWN ·Phase: PHASE3
-
Abuse Potential and Human Pharmacology of Methylone
NCT05488171 ·Status: UNKNOWN ·Phase: PHASE1
-
Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome
NCT02710084 ·Status: COMPLETED ·Phase: PHASE2
-
Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls
NCT03649555 ·Status: COMPLETED ·Phase: PHASE1
-
Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies
NCT00916253 ·Status: COMPLETED ·Phase: NA
-
Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users
NCT03152123 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Intranasal Esketamine and Its Effects on the Pharmacokinetics of Orally-Administered Midazolam and Bupropion in Healthy Participants
NCT02568176 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy Participants
NCT03808259 ·Status: COMPLETED ·Phase: PHASE1
-
[11C]Yohimbine PET Study of alpha2-AR
NCT03520543 ·Status: COMPLETED ·Phase: PHASE1
-
Oxytocin and Social Behavior Over the Lifespan
NCT00914953 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Oral and IV Baclofen in Adult Volunteers
NCT01749319 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Ketamine in Severe Pain Syndromes
NCT06537375 ·Status: COMPLETED
-
Changes in Striatal [11C]ORM-13070 Binding Elicited by Changing Levels of Endogenous Noradrenaline
NCT01794975 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants
NCT01780259 ·Status: COMPLETED ·Phase: PHASE1
-
Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)
NCT05695495 ·Status: COMPLETED ·Phase: PHASE1
-
Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin
NCT03011970 ·Status: COMPLETED ·Phase: PHASE1
-
Opiates and Benzodiazepines on Driving
NCT03447353 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Amantadine Hydrochloride for Treatment of Severe Traumatic Brain Injury (TBI)
NCT00970944 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder
NCT03143855 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Psychoactive Substance Users in Young Adults (16 to 25 Years Old) Visiting the Emergency Department
NCT04173546 ·Status: COMPLETED
-
Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder
NCT04866043 ·Status: COMPLETED
-
A Study to Evaluate Abuse Potential of Istradefylline
NCT02609477 ·Status: COMPLETED ·Phase: PHASE1
-
Measuring Acute Drug Demand in Humans
NCT05829655 ·Status: SUSPENDED ·Phase: EARLY_PHASE1
-
Physiological, Behavioral and Subjective Effects of Drugs (GHB)
NCT00058955 ·Status: COMPLETED ·Phase: PHASE1